- Joined
- Oct 10, 2011
- Messages
- 8,624
- Reaction score
- 10,698
I presume you're discusing poorer long term oncologic outcomes with the robot - LACC trial was in early stage CERVICAL cancer and even that was a mix of old school laparascopic modified radical hysterectomy (which is likely more challenging than old school TLH/BSO). Trial is being re-run evaluating Robot vs open directly given most of the poor outcomes seemed to be driven mostly by the old school laparaoscpic techniques (although not powered on subset analysis to evaluate differences based on old school laparoscopic vs robot-assisted laparoscopic)Robotics vs open in any site is not comparable to protons vs photons. Outside of lack of data indicating oncologic benefit for robotics, there are many acute toxicity reasons to do it in multiple sites. I don't believe there is a good acute toxicity rationale for most proton therapy. There certainly isn't a "time under treatment" rationale or diminished hospital recovery rationale.
Now...I believe that there is some data indicating poorer long term oncologic outcomes in some GYN cancers (early stage endometrial) and I have witnessed numerable peculiar regional failures after robot assisted thoracic surgeries (regional pleural based failures as opposed to more traditional suture line failure).
Whether a generation of surgeons is being trained in a technique that is at present oncologically inferior but progressively being used, I don't know. Curious what the thoracic surgeons and gyn/oncs think.
robot assisted TLH/BSO is a very reasonable SOC for the vast majority of endometrial cancer patients.
LARP seems to have lower hospitalization duration compared to RRP - I don't really have an issue with the urologists using the robot for things that deep in the pelvis.
That being said, there are general surgeons using the robot for a lap cholecystectomy, which I DO think is either 1) financially motivated or 2) making up for poor technical qualities of a surgeon.